Details for 2017718304
Up to date per 03.04.2026
Actions
Details for 2017718304
Deleted
European Patent
13.02.2019 A
04.08.2021 B1
07.04.2016
US
201662319648 P
A61K 31/506 20060101AFI20200626BHEP
Owner
Oyster Point Pharma, Inc.202 Carnegie Center, Suite 109 Princeton, New Jersey 08540US
Representative
No representatives present
Inventor
ACKERMANN, Douglas Michael13295 W Saddlebow Drive Reno, Nevada 89511US
LOUDIN, James107 ½ Lanewood Avenue Alhambra, California 91801US
MANDELL, Kenneth J.147 Lowell Street Arlington, Massachusetts 02474US